By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in...

Healthcare Edge sister platform IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with the Juliette Han, CFO and COO of Cambrian Bio. Ms. Han spoke to Editor-at-Large Jarrett Banks about her background as a neuroscientist,...

By Exec Edge Editorial Staff Join ICR for a webinar which is designed to provide executives with the foundations around effectively and safely harnessing the transformative potential of artificial intelligence, particularly generative AI. In this introductory session, ICR will lay...

By Exec Edge Editorial Staff FullBeauty will acquire plus-size fashion authority ELOQUII Inc. from Walmart, it said in a statement. The acquisition will allow FullBeauty to expand its presence in the $81 billion women’s plus-sized sector in the U.S. ELOQUII...

By Exec Edge Editorial Staff Morning Calm Management, a real estate management firm, said it has formed a $500 million joint venture with a global investment manager. Morning Calm Office Finance (MCOF) will provide financing solutions for office owners and...

  By Exec Edge Editorial Staff Charlotte’s Web Holdings, Inc. said it formed a joint venture with AJNA BioSciences PBC, a botanical drug development company focused on mental health and neurological disorders, and a subsidiary of British American Tobacco PLC...

  By Exec Edge Editorial Staff On March 5, crowds poured into the Museum of Fine Arts, Houston for the public debut of its Art of the Islamic Worlds gallery. It was a long-held dream finally realized for board members,...

    By Exec Edge Editorial Staff Real estate technology company reAlpha said it launched its fractional ownership platform for global short-term rentals. The platform allows accredited and non-accredited investors to add vacation rentals to their investment portfolios through “initial...

By Exec Edge Editorial Staff On Holding AG (NYSE: ONON) reported a 68.7% jump in net sales for 2022 on strong demand for its running shoes. Net sales rose to CHF 1,222.1 million, surpassing the CHF 1 billion mark for the...

  Ron Gutman says the era of the “superhero” leader is over. The inventor, investor, and co-founder of Intrivo Diagnostics believes that the model of an individualistic leader with a top-down approach to managing people is long gone. Gutman argues...